Olema Pharmaceuticals names Jason O'Byrne chief financial officer
OLMA•Olema Pharmaceuticals appointed Jason O'Byrne as chief financial officer in the third quarter of 2026.
OLMA•OLMA•OLMA•Olema Pharmaceuticals appointed Jason O'Byrne as chief financial officer in the third quarter of 2026.
Olema Pharmaceuticals appointed Jason O'Byrne as chief financial officer in the third quarter of 2026. His professional background spans corporate strategy, capital markets, financial management and operations.
